BeiGene Ltd (BGNE) reported a Q3 net loss Tuesday of $1.15 per American depositary share, swinging from earnings of $2.01 a year earlier.
Analysts polled by Capital IQ expected a loss of $0.99.
Revenue for the quarter ended Sept. 30 was $1 billion, up from $781.3 million a year earlier.
Analysts surveyed by Capital IQ expected $984.2 million.
Price: 222.99, Change: -4.06, Percent Change: -1.79
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。